These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 26825660

  • 1. Comparison of parathyroid hormone and strontium ranelate in combination with whole-body vibration in a rat model of osteoporosis.
    Hoffmann DB, Sehmisch S, Hofmann AM, Eimer C, Komrakova M, Saul D, Wassmann M, Stürmer KM, Tezval M.
    J Bone Miner Metab; 2017 Jan; 35(1):31-39. PubMed ID: 26825660
    [Abstract] [Full Text] [Related]

  • 2. The Effect of Vibration Treatments Combined with Teriparatide or Strontium Ranelate on Bone Healing and Muscle in Ovariectomized Rats.
    Komrakova M, Hoffmann DB, Nuehnen V, Stueber H, Wassmann M, Wicke M, Tezval M, Stuermer KM, Sehmisch S.
    Calcif Tissue Int; 2016 Oct; 99(4):408-22. PubMed ID: 27272029
    [Abstract] [Full Text] [Related]

  • 3. Effect of Strontium Ranelate on the Muscle and Vertebrae of Ovariectomized Rats.
    Saul D, Harlas B, Ahrabi A, Kosinsky RL, Hoffmann DB, Wassmann M, Wigger R, Böker KO, Sehmisch S, Komrakova M.
    Calcif Tissue Int; 2018 Jun; 102(6):705-719. PubMed ID: 29242963
    [Abstract] [Full Text] [Related]

  • 4. Intermittent administration of human parathyroid hormone (1-34) increases fixation of strontium-doped hydroxyapatite coating titanium implants via electrochemical deposition in ovariectomized rat femur.
    Tao ZS, Zhou WS, Qiang Z, Tu KK, Huang ZL, Xu HM, Sun T, Lv YX, Cui W, Yang L.
    J Biomater Appl; 2016 Feb; 30(7):952-60. PubMed ID: 26482573
    [Abstract] [Full Text] [Related]

  • 5. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y, Won YY, Baek MH, Lim SK.
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [Abstract] [Full Text] [Related]

  • 6. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [Abstract] [Full Text] [Related]

  • 7. Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing.
    Habermann B, Kafchitsas K, Olender G, Augat P, Kurth A.
    Calcif Tissue Int; 2010 Jan; 86(1):82-9. PubMed ID: 19960189
    [Abstract] [Full Text] [Related]

  • 8. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V, Birchman R, Wu DD, Lindsay R.
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [Abstract] [Full Text] [Related]

  • 9. Comparable effects of alendronate and strontium ranelate on femur in ovariectomized rats.
    Chen B, Li Y, Yang X, Xie D.
    Calcif Tissue Int; 2013 Nov; 93(5):481-6. PubMed ID: 23897224
    [Abstract] [Full Text] [Related]

  • 10. Effect of Concurrent Use of Whole-Body Vibration and Parathyroid Hormone on Bone Structure and Material Properties of Ovariectomized Mice.
    Matsumoto T, Itamochi S, Hashimoto Y.
    Calcif Tissue Int; 2016 May; 98(5):520-9. PubMed ID: 26746476
    [Abstract] [Full Text] [Related]

  • 11. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
    Sato M, Zeng GQ, Turner CH.
    Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
    [Abstract] [Full Text] [Related]

  • 12. The Impact of Strontium Ranelate on Metaphyseal Bone Healing in Ovariectomized Rats.
    Komrakova M, Weidemann A, Dullin C, Ebert J, Tezval M, Stuermer KM, Sehmisch S.
    Calcif Tissue Int; 2015 Oct; 97(4):391-401. PubMed ID: 26084691
    [Abstract] [Full Text] [Related]

  • 13. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE.
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [Abstract] [Full Text] [Related]

  • 14. Short-term effects of parathyroid hormone on rat lumbar vertebrae.
    Sehmisch S, Erren M, Rack T, Tezval M, Seidlova-Wuttke D, Richter J, Wuttke W, Stuermer KM, Stuermer EK.
    Spine (Phila Pa 1976); 2009 Sep 01; 34(19):2014-21. PubMed ID: 19730209
    [Abstract] [Full Text] [Related]

  • 15. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML, Massie J, Perry A, Garfin SR, Kim CW.
    Spine J; 2007 Sep 01; 7(4):466-74. PubMed ID: 17630145
    [Abstract] [Full Text] [Related]

  • 16. Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats.
    Wang L, Orhii PB, Banu J, Kalu DN.
    Bone; 2001 Feb 01; 28(2):202-7. PubMed ID: 11182379
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparison of the effects of two anabolic agents (fluoride and PTH) on ash density and bone strength assessed in an osteopenic rat model.
    Søgaard CH, Mosekilde L, Thomsen JS, Richards A, McOsker JE.
    Bone; 1997 May 01; 20(5):439-49. PubMed ID: 9145241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.